Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

959-24-0

Sotalol HCl

959-24-0
8025-81-8

Spiramycin

8025-81-8
72-14-0

Sulfathiazole

72-14-0
4478-93-7

D,L-Sulforaphane

4478-93-7
135459-87-9

Strontium ranelate

135459-87-9
6533-68-2

Scopolamine HBr

6533-68-2
122-11-2

Sulfadimethoxin

122-11-2
59-40-5

Sulfaquinoxalin

59-40-5
144-74-1

Sulfathiazole sodium salt

144-74-1
547-32-0

Sulfadiazine sodium salt

547-32-0
57-67-0

Sulfaguanidine

57-67-0
967-80-6

Sulfaquinoxaline sodium salt

967-80-6
1981-58-4

Sulfamethazine sodium salt

1981-58-4
144-82-1

Sulfamethizole

144-82-1
23307-72-4

Sulfaclozine sodium

23307-72-4
1357931-55-5

De-Me-piperazinyl Sildenafil Sulfonic Ac Imp D

1357931-55-5
130-01-8

Senecionine

130-01-8
127-69-5

Sulfisoxazole

127-69-5
13268-67-2

Senecionine N-oxide

13268-67-2
480-81-9

Seneciphylline

480-81-9